OTS is a forum to foster academic and industry-based research and development of oligonucleotide therapeutics.
Sharing the latest trends, innovations, and best practices for digitizing R&D assets to accelerate modern science.
Our explainable models yielded a 44 percentage point improvement in catching toxic drugs in the drug development pipeline
Our results-driven world pressures us to give up good science.
Abzu, an applied research startup who has developed a pioneering explainable artificial intelligence (xAI), and Contera Pharma, a biotech company developing innovative therapies to treat neurological disorders, are partnering to design nucleic acid-based medicines. Abzu will collaborate exclusively with Contera Pharma on two undisclosed targets within rare neurological diseases.
How the QLattice explains the cellular toxicity of RNA-targeting drugs.